Mikhail Inyushin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mikhail Inyushin has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Vassiliy Tsytsarev
Johns Hopkins University
13 shared publications - Lilia Kucheryavykh
Department of Biochemistry, Universidad Central del Caribe, Bayamon, PR, USA.
12 shared publications - Serguei N. Skatchkov
Department of Biochemistry, Universidad Central del Caribe, Bayamón, PR 00956, USA
11 shared publications Lidia Zueva
Universidad Central del Caribe School of Medicine Bayamon Puerto Rico
9 shared publications- Vladimir I. Makarov
Department of Physics, University of Puerto Rico, Rio Piedras Campus, San Juan, USA
9 shared publications - Yuriy V. Kucheryavykh
Department of Biochemistry, Universidad Central del Caribe, Bayamón, PR 00956, USA
9 shared publications
Latest Publications
- 1 October 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (5) , 051002
Combined voltammetry and optical brain imaging: toward high resolution neurochemical measurements
The question of the mechanisms by which cellular interactions in the brain are converted into integrative behavioral phenomena is closely related to functional localization, and also to the relationship between spatial and temporal resolution when interpreting experimental data. Classical electrophysiology is usually limited in its ability to display information about the functioning of neural circuits with sufficient spatial resolution, although the temporal resolution is almost always very high. Other modern methods for recording the functional characteristics of neural activity in the brain vary considerably in spatial and temporal resolution. Voltammetry is one of the key instrumental methods used in neurobiology to measure neurotransmitter release and dynamics in vivo . It is similar to electrophysiology in terms of temporal resolution, but spatial resolution remains low. This method records changes in the concentration of chemicals, typically neurotransmitters, in the brain’s extracellular environment with sufficient temporal resolution to capture release peaks. However, as this monitoring is performed at a single location or target, the technique does not provide information about the spatial distribution of the recorded signal characteristics. Various techniques for functional optical imaging of brain structure and activity offer relatively high spatial resolution, often accompanied by adequate temporal resolution. Some of these methods are suitable for visualizing neural activity in both 2D and 3D. However, while functional brain imaging allows areas of neural activity to be identified, it typically does not provide quantitative information about changes in the concentration levels of specific molecules. A significant challenge would be to combine the key advantages of voltammetry and functional optical brain imaging, i.e. to obtain continuous quantitative information on the concentration of neurochemically active molecules across many areas of the investigated brain region with sufficiently high temporal and spatial resolution. This review discusses the current state of voltammetry and functional optical brain imaging techniques, as well as the hypothetical possibilities for combining them based on the experimental data obtained to date.
- 1 October 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (5) , 051002
Combined voltammetry and optical brain imaging: toward high resolution neurochemical measurements
The question of the mechanisms by which cellular interactions in the brain are converted into integrative behavioral phenomena is closely related to functional localization, and also to the relationship between spatial and temporal resolution when interpreting experimental data. Classical electrophysiology is usually limited in its ability to display information about the functioning of neural circuits with sufficient spatial resolution, although the temporal resolution is almost always very high. Other modern methods for recording the functional characteristics of neural activity in the brain vary considerably in spatial and temporal resolution. Voltammetry is one of the key instrumental methods used in neurobiology to measure neurotransmitter release and dynamics in vivo . It is similar to electrophysiology in terms of temporal resolution, but spatial resolution remains low. This method records changes in the concentration of chemicals, typically neurotransmitters, in the brain’s extracellular environment with sufficient temporal resolution to capture release peaks. However, as this monitoring is performed at a single location or target, the technique does not provide information about the spatial distribution of the recorded signal characteristics. Various techniques for functional optical imaging of brain structure and activity offer relatively high spatial resolution, often accompanied by adequate temporal resolution. Some of these methods are suitable for visualizing neural activity in both 2D and 3D. However, while functional brain imaging allows areas of neural activity to be identified, it typically does not provide quantitative information about changes in the concentration levels of specific molecules. A significant challenge would be to combine the key advantages of voltammetry and functional optical brain imaging, i.e. to obtain continuous quantitative information on the concentration of neurochemically active molecules across many areas of the investigated brain region with sufficiently high temporal and spatial resolution. This review discusses the current state of voltammetry and functional optical brain imaging techniques, as well as the hypothetical possibilities for combining them based on the experimental data obtained to date.
- Open Access
Beyond SWS1 Cones: Canonical and Noncanonical Routes of Ultraviolet Sensitivity in the Avian Retina
Ultraviolet sensitivity in birds is generally attributed to short-wavelength-sensitive type 1 single cones, but ultraviolet radiation may influence the retina through several additional pathways. We reviewed molecular, optical, physiological, and behavioral evidence for canonical and putative noncanonical ultraviolet detection in the avian retina. Under photopic conditions, short-wavelength-sensitive type 1 cones provide an established chromatic pathway, whereas secondary ultraviolet absorption bands of other cone pigments may contribute at high irradiance. Under scotopic conditions, particularly in rod-dominated owls lacking functional ultraviolet- or violet-sensitive type 1 cones, the secondary ultraviolet absorption band of rhodopsin provides a plausible achromatic pathway. Ultraviolet-sensitive opsin 5 in inner-retinal neurons and Müller glia may mediate local regulatory or non-image-forming responses. We also examine fluorescence of oil droplets in double cones as a possible route into the luminance system. Previous reports described ultraviolet-induced visible fluorescence in chicken retinal oil droplets and fluorescence of chicken double-cone droplets under blue excitation, although physiological activation of the adjacent visual pigment by droplet fluorescence has not been established. These mechanisms are not mutually exclusive, and their relative contributions probably depend on irradiance, adaptation state, ocular-media transmission, receptor abundance, and behavioral context. Receptor-specific physiological and behavioral experiments are required to distinguish between them.
Open AccessBeyond SWS1 Cones: Canonical and Noncanonical Routes of Ultraviolet Sensitivity in the Avian Retina
Ultraviolet sensitivity in birds is generally attributed to short-wavelength-sensitive type 1 single cones, but ultraviolet radiation may influence the retina through several additional pathways. We reviewed molecular, optical, physiological, and behavioral evidence for canonical and putative noncanonical ultraviolet detection in the avian retina. Under photopic conditions, short-wavelength-sensitive type 1 cones provide an established chromatic pathway, whereas secondary ultraviolet absorption bands of other cone pigments may contribute at high irradiance. Under scotopic conditions, particularly in rod-dominated owls lacking functional ultraviolet- or violet-sensitive type 1 cones, the secondary ultraviolet absorption band of rhodopsin provides a plausible achromatic pathway. Ultraviolet-sensitive opsin 5 in inner-retinal neurons and Müller glia may mediate local regulatory or non-image-forming responses. We also examine fluorescence of oil droplets in double cones as a possible route into the luminance system. Previous reports described ultraviolet-induced visible fluorescence in chicken retinal oil droplets and fluorescence of chicken double-cone droplets under blue excitation, although physiological activation of the adjacent visual pigment by droplet fluorescence has not been established. These mechanisms are not mutually exclusive, and their relative contributions probably depend on irradiance, adaptation state, ocular-media transmission, receptor abundance, and behavioral context. Receptor-specific physiological and behavioral experiments are required to distinguish between them.
- Open Access
- 11 August 2026
- Published by Frontiers Media SA in Frontiers in Computational Neuroscience
- Vol. 20, 1878543
Representational recoding and capacity limits: a conceptual reinterpretation of Sidney Smith’s experiment
George A. Miller’s classic discussion of memory capacity and Sidney Smith’s recoding experiments demonstrated that cognitive limits depend more strongly on the number of active representational units (“chunks”) than on the total amount of raw information being processed. Here, we reinterpret Smith’s experiments from the perspective of modern computational neuroscience and representation learning. We argue that Smith’s recoding procedure illustrates a general principle of representational recoding, whereby learning increases the amount of information associated with each active representational unit without increasing the number of units available to the system. This principle provides conceptual links among classical theories of chunking, modern representation learning, vector symbolic architectures, and biological memory systems. The framework may offer useful guidance for future neuromorphic systems operating under strict energetic and structural constraints.
- 11 August 2026
- Published by Frontiers Media SA in Frontiers in Computational Neuroscience
- Vol. 20, 1878543
Open AccessRepresentational recoding and capacity limits: a conceptual reinterpretation of Sidney Smith’s experiment
George A. Miller’s classic discussion of memory capacity and Sidney Smith’s recoding experiments demonstrated that cognitive limits depend more strongly on the number of active representational units (“chunks”) than on the total amount of raw information being processed. Here, we reinterpret Smith’s experiments from the perspective of modern computational neuroscience and representation learning. We argue that Smith’s recoding procedure illustrates a general principle of representational recoding, whereby learning increases the amount of information associated with each active representational unit without increasing the number of units available to the system. This principle provides conceptual links among classical theories of chunking, modern representation learning, vector symbolic architectures, and biological memory systems. The framework may offer useful guidance for future neuromorphic systems operating under strict energetic and structural constraints.
- Open Access
- 1 January 2026
- Published by Wiley in Parkinson's Disease
- Vol. 2026 (1) , 5349481
Parkinson’s Disease: Immunometabolic Control Points Across Neural, Vascular, and Peripheral Systems
Parkinson’s disease (PD) is a progressive neurodegenerative disorder most associated with degeneration of dopaminergic neurons in the substantia nigra pars compacta. Increasing clinical and experimental evidence, however, indicates that PD is a multisystem disease in which immune, metabolic, vascular, and peripheral nervous system dysfunction precede and shape motor circuit failure. Nonmotor manifestations, including olfactory impairment, sleep and autonomic disturbances, gastrointestinal dysfunction, and cognitive decline, often arise years before motor diagnosis, highlighting pathogenic mechanisms beyond dopamine deficiency alone. In this review, we synthesize evidence supporting the view that PD represents a disorder of chronic immunometabolic dysregulation rather than isolated neuronal loss. We focus on underestimated but high‐impact immunological control points that integrate central and peripheral disease mechanisms, including environmental and microbial immune priming, gut–brain axis interactions, platelet‐mediated inflammatory signaling, amyloid‐β (Aβ) as an innate immune peptide, immune checkpoint regulation via the PD‐1/PD‐L1 axis, and nicotinamide adenine dinucleotide (NAD + ) homeostasis governed by nicotinamide phosphoribosyltransferase (NAMPT). Recent pharmacological evidence further supports this framework, as metabolic interventions that improve systemic energy balance and reduce inflammation have also demonstrated neuroprotective effects in experimental models, reinforcing the concept that immunometabolic pathways are therapeutically actionable. Motor impairment in PD arises from basal ganglia network dysfunction, accompanied by pathological beta‐band synchronization, which is increasingly linked to neuroinflammation and metabolic stress. In parallel, platelet activation during inflammation and vascular injury releases amyloid precursor protein and Aβ, linking systemic immune activation to neurovascular signaling. Clinical observations from immune checkpoint inhibitor therapy demonstrate that disruption of PD‐1/PD‐L1 signaling can lead to Parkinsonism and neuroinflammatory syndromes, underscoring the importance of immune restraint in neural homeostasis. Finally, we highlight NAMPT‐dependent NAD + salvage as an important immunometabolic hub integrating energy metabolism, inflammation, and neuronal survival. Together, these findings support a unifying framework in which PD reflects failure of immunometabolic control across neural and peripheral systems, suggesting new avenues for disease‐modifying therapeutic strategies beyond symptomatic dopamine replacement.
- 1 January 2026
- Published by Wiley in Parkinson's Disease
- Vol. 2026 (1) , 5349481
Open AccessParkinson’s Disease: Immunometabolic Control Points Across Neural, Vascular, and Peripheral Systems
Parkinson’s disease (PD) is a progressive neurodegenerative disorder most associated with degeneration of dopaminergic neurons in the substantia nigra pars compacta. Increasing clinical and experimental evidence, however, indicates that PD is a multisystem disease in which immune, metabolic, vascular, and peripheral nervous system dysfunction precede and shape motor circuit failure. Nonmotor manifestations, including olfactory impairment, sleep and autonomic disturbances, gastrointestinal dysfunction, and cognitive decline, often arise years before motor diagnosis, highlighting pathogenic mechanisms beyond dopamine deficiency alone. In this review, we synthesize evidence supporting the view that PD represents a disorder of chronic immunometabolic dysregulation rather than isolated neuronal loss. We focus on underestimated but high‐impact immunological control points that integrate central and peripheral disease mechanisms, including environmental and microbial immune priming, gut–brain axis interactions, platelet‐mediated inflammatory signaling, amyloid‐β (Aβ) as an innate immune peptide, immune checkpoint regulation via the PD‐1/PD‐L1 axis, and nicotinamide adenine dinucleotide (NAD + ) homeostasis governed by nicotinamide phosphoribosyltransferase (NAMPT). Recent pharmacological evidence further supports this framework, as metabolic interventions that improve systemic energy balance and reduce inflammation have also demonstrated neuroprotective effects in experimental models, reinforcing the concept that immunometabolic pathways are therapeutically actionable. Motor impairment in PD arises from basal ganglia network dysfunction, accompanied by pathological beta‐band synchronization, which is increasingly linked to neuroinflammation and metabolic stress. In parallel, platelet activation during inflammation and vascular injury releases amyloid precursor protein and Aβ, linking systemic immune activation to neurovascular signaling. Clinical observations from immune checkpoint inhibitor therapy demonstrate that disruption of PD‐1/PD‐L1 signaling can lead to Parkinsonism and neuroinflammatory syndromes, underscoring the importance of immune restraint in neural homeostasis. Finally, we highlight NAMPT‐dependent NAD + salvage as an important immunometabolic hub integrating energy metabolism, inflammation, and neuronal survival. Together, these findings support a unifying framework in which PD reflects failure of immunometabolic control across neural and peripheral systems, suggesting new avenues for disease‐modifying therapeutic strategies beyond symptomatic dopamine replacement.
- Open Access
- 28 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10450
Targeting Gliomas with Beta-Amyloid-Specific Dyes: A Novel Approach for In Vivo Staining and Potential Therapeutic Applications
Gliomas, the most common primary brain tumors, present significant diagnostic and treatment challenges due to their infiltrative nature and heterogeneity. Our previous research revealed that glioma tumors in both animals and humans accumulate beta-amyloid protein (Aβ), detectable through immunohistochemical methods or staining with amyloid-specific dyes. We hypothesize that beta-amyloid-specific dyes could serve as glioma markers, potentially enabling the delineation of glioma tumors or targeted therapeutics delivery. In this study, the specificity and blood-brain barrier permeability of two fluorescent beta-amyloid-specific dyes, Brilliant Blue G (BBG) and BODIPY-based Amyloid Probe-1 (BAP-1), were evaluated in C57Bl/6 mouse glioma implantation models using GL261 and KR158 glioma cells. The findings demonstrate that both BBG and BAP-1 selectively stain gliomas, providing a clear contrast from normal brain tissue. The study results open avenues for further development of glioma visualization methods and targeted therapeutic delivery strategies for clinical applications.
- 28 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10450
Open AccessTargeting Gliomas with Beta-Amyloid-Specific Dyes: A Novel Approach for In Vivo Staining and Potential Therapeutic Applications
Gliomas, the most common primary brain tumors, present significant diagnostic and treatment challenges due to their infiltrative nature and heterogeneity. Our previous research revealed that glioma tumors in both animals and humans accumulate beta-amyloid protein (Aβ), detectable through immunohistochemical methods or staining with amyloid-specific dyes. We hypothesize that beta-amyloid-specific dyes could serve as glioma markers, potentially enabling the delineation of glioma tumors or targeted therapeutics delivery. In this study, the specificity and blood-brain barrier permeability of two fluorescent beta-amyloid-specific dyes, Brilliant Blue G (BBG) and BODIPY-based Amyloid Probe-1 (BAP-1), were evaluated in C57Bl/6 mouse glioma implantation models using GL261 and KR158 glioma cells. The findings demonstrate that both BBG and BAP-1 selectively stain gliomas, providing a clear contrast from normal brain tissue. The study results open avenues for further development of glioma visualization methods and targeted therapeutic delivery strategies for clinical applications.
- Open Access
- 26 September 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-7
Amyloid precursor protein accumulation in glioblastoma is associated with altered synaptic dynamics and immune suppression
Increased amyloid precursor protein (APP), including both mRNA and protein expression, has been linked to glioblastoma (GBM) yet the physiological effects are poorly understood. In this study, we investigated the relationship between APP protein abundance and mRNA expression in GBM. Gene set enrichment analysis revealed significant positive enrichment of neuron projection and synaptic junction gene sets from Gene Ontology. Additionally, several immune-related processes were negatively enriched, suggesting a broad immune suppression associated with increased presence of APP. These findings suggest a multi-faceted role of APP, linking its presence to modulation of synaptic activity as well as the immune microenvironment in GBM tumors.
- 26 September 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-7
Open AccessAmyloid precursor protein accumulation in glioblastoma is associated with altered synaptic dynamics and immune suppression
Increased amyloid precursor protein (APP), including both mRNA and protein expression, has been linked to glioblastoma (GBM) yet the physiological effects are poorly understood. In this study, we investigated the relationship between APP protein abundance and mRNA expression in GBM. Gene set enrichment analysis revealed significant positive enrichment of neuron projection and synaptic junction gene sets from Gene Ontology. Additionally, several immune-related processes were negatively enriched, suggesting a broad immune suppression associated with increased presence of APP. These findings suggest a multi-faceted role of APP, linking its presence to modulation of synaptic activity as well as the immune microenvironment in GBM tumors.
- 19 August 2025
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 19 (S1) , S104-S116
Transplanted Cells, Transferred Minds: Can Transplanted Cells Influence Mental Illness? (A Review)
Mental disorders such as schizophrenia, major depressive disorder, autism spectrum disorders, and various psychoses exhibit incredibly diverse clinical presentations, with symptoms varying significantly among patients. Numerous studies have provided substantial evidence that genetic factors play a major role in the development of such conditions, particularly schizophrenia. However, the genetics of schizophrenia and other mental disorders are highly complex. The development of these diseases is influenced not only by genetic factors, but also by other, often unidentified, contributors. For a long time, this led to the belief that the pathogenesis of major psychiatric disorders—primarily schizophrenia—could not be directly linked to transmissible processes. In other words, it was considered impossible for a mental illness to be transmitted from one person to another. In recent years, however, some findings have challenged this assumption. There have been reports of schizophrenia-like symptoms emerging in recipients of bone marrow transplants from donors diagnosed with schizophrenia, as well as cases of sustained remission in patients with schizophrenia following transplantation from donors without any psychiatric history. Experimental animal models have also provided evidence supporting the plausibility of such a mechanism. While these mechanisms cannot alter the recipient’s genotype, they likely have the potential to initiate or suppress pathological processes. At present, there is no widely accepted biological explanation for how these effects occur. Nonetheless, ongoing research in this area appears crucial for understanding the pathogenesis of mental disorders and for developing innovative therapeutic strategies. The aim of this review is to summarize current research on the potential role of transmissible mechanisms in schizophrenia and other neuropsychiatric disorders, and to explore how these findings may inform the development of novel therapeutic approaches.
- 19 August 2025
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 19 (S1) , S104-S116
Transplanted Cells, Transferred Minds: Can Transplanted Cells Influence Mental Illness? (A Review)
Mental disorders such as schizophrenia, major depressive disorder, autism spectrum disorders, and various psychoses exhibit incredibly diverse clinical presentations, with symptoms varying significantly among patients. Numerous studies have provided substantial evidence that genetic factors play a major role in the development of such conditions, particularly schizophrenia. However, the genetics of schizophrenia and other mental disorders are highly complex. The development of these diseases is influenced not only by genetic factors, but also by other, often unidentified, contributors. For a long time, this led to the belief that the pathogenesis of major psychiatric disorders—primarily schizophrenia—could not be directly linked to transmissible processes. In other words, it was considered impossible for a mental illness to be transmitted from one person to another. In recent years, however, some findings have challenged this assumption. There have been reports of schizophrenia-like symptoms emerging in recipients of bone marrow transplants from donors diagnosed with schizophrenia, as well as cases of sustained remission in patients with schizophrenia following transplantation from donors without any psychiatric history. Experimental animal models have also provided evidence supporting the plausibility of such a mechanism. While these mechanisms cannot alter the recipient’s genotype, they likely have the potential to initiate or suppress pathological processes. At present, there is no widely accepted biological explanation for how these effects occur. Nonetheless, ongoing research in this area appears crucial for understanding the pathogenesis of mental disorders and for developing innovative therapeutic strategies. The aim of this review is to summarize current research on the potential role of transmissible mechanisms in schizophrenia and other neuropsychiatric disorders, and to explore how these findings may inform the development of novel therapeutic approaches.
- Open Access
- 7 July 2025
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 19, 1612626
Vectorial principles of sensorimotor decoding
This review explores the vectorial principles underlying sensorimotor decoding across diverse biological systems. From the encoding of light wavelength in retinal cones to direction-specific motor cortex activity in primates, neural representations frequently rely on population vector coding–a scheme, in which neurons with directional or modality-specific preferences integrate their activity to encode stimuli or motor commands. Early studies on color vision and motor control introduced concepts of vector summation and neuronal tuning, evolving toward more precise models such as the von Mises distribution. Research in invertebrates, including leeches and snails, reveals that even simple nervous systems utilize population vector principles for reflexes and coordinated movements. Furthermore, analysis of joint limb motion suggests biomechanical optimization aligned with Fibonacci proportions, facilitating efficient neural and mechanical control. The review highlights that motor units and neurons often display multimodal or overlapping tuning fields, reinforcing the need for population-based decoding strategies. These findings suggest a unifying vectorial framework for sensory and motor coding, with implications for periprosthetic and brain-machine interface.
- 7 July 2025
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 19, 1612626
Open AccessVectorial principles of sensorimotor decoding
This review explores the vectorial principles underlying sensorimotor decoding across diverse biological systems. From the encoding of light wavelength in retinal cones to direction-specific motor cortex activity in primates, neural representations frequently rely on population vector coding–a scheme, in which neurons with directional or modality-specific preferences integrate their activity to encode stimuli or motor commands. Early studies on color vision and motor control introduced concepts of vector summation and neuronal tuning, evolving toward more precise models such as the von Mises distribution. Research in invertebrates, including leeches and snails, reveals that even simple nervous systems utilize population vector principles for reflexes and coordinated movements. Furthermore, analysis of joint limb motion suggests biomechanical optimization aligned with Fibonacci proportions, facilitating efficient neural and mechanical control. The review highlights that motor units and neurons often display multimodal or overlapping tuning fields, reinforcing the need for population-based decoding strategies. These findings suggest a unifying vectorial framework for sensory and motor coding, with implications for periprosthetic and brain-machine interface.
- 22 October 2024
- Vol. 40 (4) , 485-492
Impact of 6-OHDA injection and microtrauma in the rat substantia nigra on local brain amyloid beta protein concentrations in the affected area.
Amyloid beta peptides (Aβ) are key indicators of Alzheimer's disease and are also linked to cognitive decline in Parkinson's disease (PD) and other neurodegenerative disorders. This study explored the accumulation of Aβ in a standard 6-Hydroxydopamine (6-OHDA) model of PD. We unilaterally injected 6-OHDA into the substantia nigra of Wistar rats to induce dopaminergic cell degeneration and death, a characteristic of PD. The goal was to detect Aβ protein in tissues and blood vessels showing inflammation or degeneration from the 6-OHDA injection. Our results showed that 6-OHDA injection produced a statistically significant rise in Aβ concentration at the injection site 60 minutes after injection, which was slightly reduced 24 hours post-injection but still significantly higher than in controls. We also tried Gp120 injection in the same zone but it only produced effects comparable to control needle trauma. The presence of Aβ in tissues and blood vessel walls after injection was confirmed through ELISA tests and was supported by immunohistochemical staining of injection areas. We found that the increased Aβ concentration was visible in and around blood vessels and inside blood vessel walls, and also, to a lesser extent in some cells, most probably neurons, in the area. This research highlights the connection between dopaminergic cell poisoning and the accumulation of Aβ, offering insights into the progression of PD to cognitive disorders and dementia.
- 22 October 2024
- Vol. 40 (4) , 485-492
Impact of 6-OHDA injection and microtrauma in the rat substantia nigra on local brain amyloid beta protein concentrations in the affected area.
Amyloid beta peptides (Aβ) are key indicators of Alzheimer's disease and are also linked to cognitive decline in Parkinson's disease (PD) and other neurodegenerative disorders. This study explored the accumulation of Aβ in a standard 6-Hydroxydopamine (6-OHDA) model of PD. We unilaterally injected 6-OHDA into the substantia nigra of Wistar rats to induce dopaminergic cell degeneration and death, a characteristic of PD. The goal was to detect Aβ protein in tissues and blood vessels showing inflammation or degeneration from the 6-OHDA injection. Our results showed that 6-OHDA injection produced a statistically significant rise in Aβ concentration at the injection site 60 minutes after injection, which was slightly reduced 24 hours post-injection but still significantly higher than in controls. We also tried Gp120 injection in the same zone but it only produced effects comparable to control needle trauma. The presence of Aβ in tissues and blood vessel walls after injection was confirmed through ELISA tests and was supported by immunohistochemical staining of injection areas. We found that the increased Aβ concentration was visible in and around blood vessels and inside blood vessel walls, and also, to a lesser extent in some cells, most probably neurons, in the area. This research highlights the connection between dopaminergic cell poisoning and the accumulation of Aβ, offering insights into the progression of PD to cognitive disorders and dementia.
- Open Access
- 25 September 2024
- Published by MDPI AG in Biophysica
- Vol. 4 (4) , 466-476
Melanin in the Retinal Epithelium and Magnetic Sensing: A Review of Current Studies
Coming in a variety of forms, melanin is one of the most abundant, stable, diverse, and evolutionarily ancient pigments found in living things in nature. These pigments often serve protective functions, typically well-adapted to their specific roles. One such protective function is metal chelation and cation exchange, which help regulate and buffer metal concentrations within cells. By binding to certain metals, melanin can acquire magnetic properties. Because of this, it may play a role in magnetic effects and possibly in the response of organisms to external magnetic fields and magnetic sensing. While there is melanin in plants, microbes, fungi, and invertebrates, certain types of melanin are specifically associated with the retina in vertebrates, including migrating bird and fish species. In this review, we examine studies focusing on the properties of melanin in these parts of the body and their possible association with magnetic sensing, and generally, magnetic sensing in the retina.
- 25 September 2024
- Published by MDPI AG in Biophysica
- Vol. 4 (4) , 466-476
Open AccessMelanin in the Retinal Epithelium and Magnetic Sensing: A Review of Current Studies
Coming in a variety of forms, melanin is one of the most abundant, stable, diverse, and evolutionarily ancient pigments found in living things in nature. These pigments often serve protective functions, typically well-adapted to their specific roles. One such protective function is metal chelation and cation exchange, which help regulate and buffer metal concentrations within cells. By binding to certain metals, melanin can acquire magnetic properties. Because of this, it may play a role in magnetic effects and possibly in the response of organisms to external magnetic fields and magnetic sensing. While there is melanin in plants, microbes, fungi, and invertebrates, certain types of melanin are specifically associated with the retina in vertebrates, including migrating bird and fish species. In this review, we examine studies focusing on the properties of melanin in these parts of the body and their possible association with magnetic sensing, and generally, magnetic sensing in the retina.